Alveolar-arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalized with community acquired pneumonia

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 9, 2008, Pages 1032-1037

  Moammar, Mahmoud Q ^a   Azam, Hamad M ^b   Blamoun, Adel I ^a   Rashid, Ashraf O ^a   Ismail, Medhat ^c   Khan, M Anees ^a   DeBari, Vincent A ^a  

^a SETON HALL UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

Author keywords

Alveolar arterial oxygen gradient; Community acquired pneumonia; Decision analysis; Pneumonia severity index

Indexed keywords

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; RETROSPECTIVE STUDY; SURVIVAL; TEACHING HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; BRONCHIAL ARTERIES; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PNEUMONIA, BACTERIAL; PROGNOSIS; PULMONARY ALVEOLI; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 48749132764     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04971.x     Document Type: Article

References (31)

1. Schnoor M, Heidicke J, Dalhoff K, Raspe H, Schafer T, CAPNITZ Study Group. Approaches to estimate the population-based incidence of community acquired pneumonia. J. Infect. 2007 55 : 233 9.
2. Calzada SR, Tomas RM, Romero MJ, Moragon EM, Cataluna JJ, Villanueva RM. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and readmission. Respir. Med. 2007 101 : 1909 15.
3. Fishbane S, Niederman MS, Daly C et al. The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Arch. Intern. Med. 2007 167 : 1664 9.
4. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000 162 : 1415 20.
5. Lutifiyya MN, Henley E, Chang LF. Diagnosis and treatment of community-acquired pneumonia. Am. Fam. Physician. 2006 73 : 442 50.
6. Fine MJ, Medsger AR, Stone RA et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch. Intern. Med. 1997 157 : 47 56.
7. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997 336 : 243 50.
8. Lee RW, Lindstrom ST. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia. Respirology 2007 12 : 754 8.
9. Wagner PD, West JB. Ventilation, blood flow and gas exchange. In : Murray JF, Nadel JA, Mason RJ, Broadus VC (eds). Textbook of Respiratory Medicine. Elsevier, Philadelphia. 2005 75 7.
10. Markowski EP. Inference using near-neighbor trimmed rank statistics for simple linear regression models. Biometrika 1984 71 : 51 6.
11. DeBari VA. Computation of decision levels from differentiated logistic regression probability curves. Ann. Clin. Lab. Sci. 2006 36 : 194 200.
12. Pezzullo JC, Sullivan KM. Logistic Regression (online). Available from: http://statpages.org/ [Accessed 2 May 2008].
13. Glantz SJ. Primer of Biostatistics, the Program. McGraw-Hill, New York. 2002.
14. Research Committee of the British Thoracic Society Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982-83: A survey of aetiology, mortality, prognostic factors and outcome. Q. J. Med. 1987 62 : 195 220.
15. Lim WS, Van der Erden MM, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003 58 : 377 82.
16. Conte HA, Chen Y-T, Mehal W, Scinto JD, Quagliarello VJ. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am. J. Med. 1999 106 : 20 8.
17. Higuchi T, Ota K, Tanabe Y, Suzuki E, Gejyo F. Severity classification and prognosis in hospitalized elderly patients with community-acquired pneumonia. Nippon Ronen Igakki Zasshi 2007 44 : 483 9 (in Japanese).
18. British Thoracic Society, Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. Severity assessment criteria recommended by the British thoracic Society (BTS) for community-acquired pneumonia. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006 35 : 286 91.
19. Leroy O, Devos P, Guery B et al. Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest 1999 116 : 157 65.
20. Tabernero Huguet E, Lobo Beristain JL, Sanchez Fernandez M, Lopetegui Eraso P, Zorilla V, Espana Yandiola PP. Evaluation of a computer predictive model to stratify risk and site of care in community acquired pneumonia. An. Med. Interna 2007 24 : 120 4 (in Spanish).
21. Arnold FW, Ramirez JA, McDonald LC, Xia EL. Hospitalization for community-acquired pneumonia. The pneumonia severity index vs clinical judgement. Chest 2003 124 : 121 4.
22. Etzion O, Novack V, Avnon L et al. Characteristics of low-risk patients hospitalized with community-acquired pneumonia. Eur. J. Intern. Med. 2007 18 : 209 14.
23. Phua J, Koay ES, Zhang D et al. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur. Respir. J. 2006 28 : 695 702.
24. Tejera A, Santolaria F, Diez ML et al. Prognosis of community-acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007 38 : 117 23.
25. Prat C, Lacoma A, Dominguez J et al. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J. Infect. 2007 55 : 400 7.
26. Christ-Crain M, Stolz D, Jutla S et al. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am. J. Respir. Crit Care Med. 2007 176 : 913 20.
27. Muller B, Morgenthaler N, Stolz D et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory infections. Eur. J. Clin. Invest. 2007 37 : 145 52.
28. Arozullah AM, Yarnold PR, Weinstein RA et al. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am. J. Respir. Crit. Care Med. 2000 161 : 1081 6.
29. Caldera AE, Crespo GJ, Maraj S, Kotler M, Braitman LE, Eiger G. Electrocardiogram in Pneumocystis carinii pneumonia: Can it be used as a prognostic variable? Crit. Care Med. 2002 30 : 1425 8.
30. Fernandez Cruz A, Pulido Ortega F, Pena S et al. Prognostic factors of mortality during the episode of pneumonia due to Pneumocystis carinii in patients with HIV infection. Rev. Clin. Esp. 2002 202 : 416 20 (in Spanish).
31. Christ-Crain M, Morgenthaler NG, Stolz D et al. Pro-adrenoedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit. Care 2006 10 : R96.